Innovative Drugs to Restore Neurological Function
BioAxone BioSciences Inc. is focused on the development of innovative drugs to restore neurological function and improve quality of life for patients with spinal cord injury and neurotrauma.
Our lead product, Cethrin™ is a proprietary biological drug, and our clinical Phase 2b program is paving the way as the most advanced treatment for spinal cord injury.
Phase II clinical results show enormous promise of Cethrin to promote meaningful and substantial recovery and to safely advance the road to repair.
Posted by bioadmin on Jan 2, 2012
Jan 5, 2013 by bioadmin
Dr. Lisa McKerracher will participate on panel at Biotech Showcase 2013 entitled “Spinal Cord Injury: Investment Opportunities and...
Nov 28, 2012 by bioadmin
CAMBRIDGE, MA., Nov 28, 2012. BioAxone BioSciences celebrates official opening of clinical and research operations in Cambridge,...
Posted on Jan 5, 2013
Posted on Nov 28, 2012
Posted on Jan 2, 2012
Posted on Jan 1, 2012